Press Releases

Rigel Announces Third Quarter 2017 Financial Results and Provides Company Update

Nov 07, 2017 4:01pm EST

Rigel Welcomes Gregg Lapointe to Board of Directors

Nov 02, 2017 7:30am EDT

Rigel Announces Conference Call and Webcast to Report Third Quarter 2017 Financial Results

Oct 31, 2017 7:30am EDT

Rigel Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Option To Purchase Additional Shares

Oct 10, 2017 4:01pm EDT

Rigel Announces Pricing Of Public Offering Of Common Stock

Oct 04, 2017 10:36pm EDT

Rigel Announces Proposed Public Offering Of Common Stock

Oct 03, 2017 4:01pm EDT

Fostamatinib Meets Pre-Specified Primary Endpoint in Stage 1 of Autoimmune Hemolytic Anemia (AIHA) Phase 2 Study

Oct 03, 2017 7:30am EDT

Rigel Provides Update on FDA Review of Fostamatinib for ITP

Oct 02, 2017 7:30am EDT

Rigel to Present at Cantor Fitzgerald Global Healthcare Conference

Sep 19, 2017 7:30am EDT

Rigel Welcomes Brian Kotzin, M.D. to Board of Directors

Aug 25, 2017 7:30am EDT